Luciferase assays show that the Dm element acts only as a weak transcriptional enhancer which is about sevenfold weaker than the core intronic enhancer in M12 B cell lymphoma cells (Figure 1C), suggesting that the Dm element on its own does not exert its effect by direct transcriptional activation. Here, DMPK is linked to B-cell non-Hodgkin lymphoma.